BIOVENTIX PLC Logo

BIOVENTIX PLC

Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.

BVXP | IL

Overview

Corporate Details

ISIN(s):
GB00B4QVDF07
LEI:
213800225MHX7LZQY108
Country:
United Kingdom
Address:
7 ROMANS BUSINESS PARK, GU9 7SX FARNHAM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bioventix PLC is a biotechnology company specializing in the development and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized as critical components in clinical diagnostic applications, primarily for automated immunoassays used in blood testing. The company supports healthcare organizations by creating novel SMAs, with a development timeline of approximately nine months from initial immunisation to the delivery of purified antibodies for evaluation. Its product portfolio includes a range of SMAs for the global clinical diagnostics market and ELISA kits designed to monitor exposure to industrial pollutants. The company's antibodies are instrumental in various diagnostic areas, including troponin assays for assessing cardiac conditions and research into neurological disorders like Alzheimer's disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-04 17:10
AGM Information
Result of AGM
English 8.2 KB
2025-11-26 10:00
Director's Dealing
Director Dealing
English 18.4 KB
2025-11-18 11:40
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-11-11 08:25
Report Publication Announcement
Posting of Annual Report and Notice of AGM
English 8.8 KB
2025-10-30 08:00
Director's Dealing
Director Dealing
English 19.2 KB
2025-10-27 16:53
Director's Dealing
Director Dealing
English 19.1 KB
2025-08-13 15:19
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-04-28 18:13
Director's Dealing
Director Dealing
English 19.8 KB
2025-03-31 08:00
Interim / Quarterly Report
Interim Results
English 106.1 KB
2024-12-24 10:14
Director's Dealing
Director Dealing
English 19.3 KB
2024-12-06 08:00
AGM Information
Result of AGM
English 8.1 KB
2024-12-04 16:34
Major Shareholding Notification
Holding(s) in Company
English 52.9 KB
2024-11-22 16:56
Director's Dealing
Director/PDMR Shareholding
English 19.5 KB
2024-11-08 08:57
Report Publication Announcement
Notice of AGM
English 8.1 KB
2024-10-31 08:00
Director's Dealing
Director/PDMR Shareholding
English 19.2 KB

Automate Your Workflow. Get a real-time feed of all BIOVENTIX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOVENTIX PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOVENTIX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Develops medical devices, diagnostics, nutritionals, and pharmaceuticals for global health.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900

Talk to a Data Expert

Have a question? We'll get back to you promptly.